Once-weekly glucagon-like peptide-1 receptor agonists: An overview

被引：0
|
作者：
Magwire, Melissa [1 ]
机构：
[1] Shawnee Mission Endocrinol & Diabet, Georgetown Med Bldg,8901 W 74th St,Suite 269, Shawnee, KS 66204 USA
来源：
JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS | 2018年 / 30卷
关键词：
ADHERENCE; DEPRESSION; MANAGEMENT;
D O I：
10.1097/JXX.0000000000000119
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：S2 / S3
页数：2
相关论文
共 50 条
  • [41] Glycemic Efficacy, Weight Effects, and Safety of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists (vol 24, pg S14, 2018)
    Handelsman, Y.
    Wyne, K.
    Cannon, A.
    Shannon, M.
    Schneider, D.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (11): : 1111 - 1111
  • [42] Once-weekly glucagon-like peptide-1 receptor agonists vs dipeptidyl peptidase-4 inhibitors: cardiovascular effects in people with diabetes and cardiovascular disease
    Xi Tan
    Yuanjie Liang
    Jigar R. Rajpura
    Larisa Yedigarova
    Josh Noone
    Lin Xie
    Silvio Inzucchi
    Adam de Havenon
    Cardiovascular Diabetology, 22
  • [43] Network Meta-analysis of Once Weekly Glucagon-Like Peptide-1 Receptor Agonists: A Focus on Cardiovascular Safety and Mortality
    Alfayez, Osamah
    Almohammed, Omar A.
    Alkhezi, Omar
    Al Yami, Majed S.
    DIABETES, 2020, 69
  • [44] Benefits and Harms of Once-Weekly Glucagon-like Peptide-1 Receptor Agonist Treatments A Systematic Review and Network Meta-analysis
    Zaccardi, Francesco
    Htike, Zin Zin
    Webb, David R.
    Khunti, Kamlesh
    Davies, Melanie J.
    ANNALS OF INTERNAL MEDICINE, 2016, 164 (02) : 102 - +
  • [45] Hydrocarbon-Stitched Peptide Agonists of Glucagon-Like Peptide-1 Receptor
    Bird, Gregory H.
    Fu, Accalia
    Escudero, Silvia
    Godes, Marina
    Opoku-Nsiah, Kwadwo
    Wales, Thomas E.
    Cameron, Michael D.
    Engen, John R.
    Danial, Nika N.
    Walensky, Loren D.
    ACS CHEMICAL BIOLOGY, 2020, 15 (06) : 1340 - 1348
  • [46] Effects of gastric inhibitory polypeptide, glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists on Bone Cell Metabolism
    Hansen, Morten S. S.
    Tencerova, Michaela
    Frolich, Jacob
    Kassem, Moustapha
    Frost, Morten
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 122 (01) : 25 - 37
  • [47] An overview of glucagon-like peptide-1 receptor agonists for the treatment of metabolic syndrome: A drug repositioning
    Rameshrad, Maryam
    Razavi, Bibi Marjan
    Lalau, Jean-Daniel
    De Broe, Marc E.
    Hosseinzadeh, Hossein
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2020, 23 (05) : 556 - 568
  • [48] Glucagon-like peptide-1 receptor
    Krashes, Michael
    CURRENT BIOLOGY, 2024, 34 (23) : R1163 - R1164
  • [49] Overview of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Patients with Type 2 Diabetes
    Tran, Kelvin Lingjet
    Park, Young In
    Pandya, Shalin
    Muliyil, Navin John
    Jensen, Brandon David
    Huynh, Kovin
    Nguyen, Quang T.
    AMERICAN HEALTH AND DRUG BENEFITS, 2017, 10 (04): : 178 - 187
  • [50] Efficacy and safety of once-weekly glucagon-like peptide-1 receptor agonists compared with exenatide and liraglutide in type 2 diabetes: a systemic review of randomised controlled trials
    Xue, X.
    Ren, Z.
    Zhang, A.
    Yang, Q.
    Zhang, W.
    Liu, F.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2016, 70 (08) : 649 - 656
12345